GSK Plc Director/PDMR Shareholding

 
TIDMGSK 
 
GSK plc (the 'Company') 
 
                           Transaction notification 
 
1.   Details of PDMR/person closely associated with them ('PCA�&# 
     65533;) 
 
a)   Name              Dr H Barron 
 
b)   Position/status   Chief Scientific Officer and President, R&D 
 
c)   Initial           Initial notification 
     notification/ 
     amendment 
 
2.   Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
 
a)   Name              GSK plc 
 
b)   LEI               5493000HZTVUYLO1D793 
 
3.   Details of the transaction(s): section to be repeated for (i) each 
     type of instrument; (ii) each type of transaction; (iii) each date; 
     and (iv) each place where transaction(s) has been conducted 
 
a)   Description of    American Depositary Shares ('ADSs') 
     the financial 
     instrument        ISIN: US37733W1053 
 
b)   Nature of the     Acquisition of notional ADSs within Dr Barron's 
     transaction       GSK Executive Supplemental Savings Plan account. 
 
 
c)   Price(s) and         Price(s)               Volume(s) 
     volume(s) 
                          $44.7500               1,151.020 
 
d)   Aggregated        N/A (single transaction) 
     information 
 
     Aggregated volume 
     Price 
 
e)   Date of the       2022-05-23 
     transaction 
 
f)   Place of the      New York Stock Exchange (XNYS) 
     transaction 
 
 
 
END 
 
 

(END) Dow Jones Newswires

May 25, 2022 10:41 ET (14:41 GMT)